Sort
23,748 grants matching “melanoma”
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells
$334,911Glen N. Barber · University Of Miami School Of Medicine · R01 · FY2018 · CA
Epigenetic Regulation of Immune Genes in Cancer Treatment and Vaccine Protocols
$334,818Thomas B Tomasi · Roswell Park Cancer Institute Corp · R01 · FY2010 · CA
Annotating the Role of Dysregulated Inositol Phosphate Metabolism in Malignant Ca
$334,803Daniel Nomura · University Of California Berkeley · R01 · FY2016 · CA
IMPACT OF AICD ON TCR TRANSDUCED T CELLS FOR ADOPTIVE IMMUNOTHERAPY
$334,756Michael I Nishimura · Loyola University Chicago · P01 · FY2015 · CA
Adoptive T Cell Therapy of Melanoma Targeting NY-ESO-1
$334,740Cassian Yee · Fred Hutchinson Cancer Research Center · R01 · FY2006 · CA
CANCER AND LEUKEMIA GROUP B--RPCI/SUNYAB
$334,685Roswell Park Cancer Institute Corp · U10 · FY2001 · CA
A novel therapeutic strategy to eradicate breast cancer through Hsp90 inhibition and reduced immune tolerance
$334,662Ahmed Chadli · Augusta University · R01 · FY2024 · CA
Targeted Combination Therapy for Melanoma
$334,517Meenhard Herlyn · Wistar Institute · P50 · FY2015 · CA
INHIBITION OF THE ANTICANCER TARGET GLYOXALASE I
$334,431University Of Maryland Balt Co Campus · R01 · FY2001 · CA
VISTA, a novel checkpoint that suppresses anti-tumor T cell responses
$334,420Li Lily Wang · Dartmouth College · R01 · FY2012 · CA
MPK -1 ERK SUBSTRATES AND THE CONTROL OF GERMLINE DEVELOPMENT
$334,400Tim B. Schedl · Washington University · R01 · FY2008 · GM
MPK -1 ERK SUBSTRATES AND THE CONTROL OF GERMLINE DEVELOPMENT
$334,400Tim B. Schedl · Washington University · R01 · FY2009 · GM
Cancer and Leukemia Group B
$334,393Eric P Winer · Dana-Farber Cancer Inst · U10 · FY2006 · CA
WUMC-Cancer and Leukemia Group B
$334,381Nancy L Bartlett · Washington University · U10 · FY2007 · CA
Mechanisms of Selective Therapeutic Synergy of PARP-inhibition and CTLA4 Blockade Engaged by Interferon-gamma in the Ovarian Tumor Microenvironment
$334,312Sarah Foster Adams · University Of New Mexico Health Scis Ctr · R37 · FY2024 · CA
Adoptive T Cell Therapy of Melanoma Targeting NY-ESO-1
$334,292Cassian Yee · Fred Hutchinson Cancer Research Center · R01 · FY2007 · CA
IL-2 Neuropsychiatric Symptoms: Mechanisms, Prevention
$334,267Dominique L. Musselman · Emory University · R01 · FY2009 · MH
IL-2 Neuropsychiatric Symptoms: Mechanisms, Prevention
$334,267Andrew H Miller · Emory University · R01 · FY2010 · MH
DNA and protein reactions of NO', ONOO-, and reactive species produced by phagocy
$334,226Peter C Dedon · Massachusetts Institute Of Technology · P01 · FY2013 · CA
Annotating the Role of Dysregulated Inositol Phosphate Metabolism in Malignant Ca
$334,226Daniel Nomura · University Of California Berkeley · R01 · FY2015 · CA
Molecular Aspects of Antitumor Antibodies
$334,226Jeffrey Victor Ravetch · Rockefeller University · R01 · FY2010 · CA
Therapeutic Potential of IL-15 Plasmid Delivery to Tumors Using Electroporation
$334,194Richard Heller · Old Dominion University · R01 · FY2009 · CA
Molecular Aspects of Antitumor Antibodies
$334,182Jeffrey Victor Ravetch · Rockefeller University · R01 · FY2006 · CA
Media Literacy Intervention for Indoor Tanning Prevention
$334,130Hyunyi Cho · Purdue University · R01 · FY2014 · CA
Prevention of UV-induced carcinogenesis by cyanidin-3-glucoside
$334,125Xianglin Shi · University Of Kentucky · R01 · FY2015 · ES